Patient (N) | OD ratio (sample/control) | |||||
---|---|---|---|---|---|---|
Months | ||||||
0 | 1 | 2 | 3 | 4 | 5 | |
1 | 2.01 (+) | 2.17 | 1.63 | 1.60 | 0.95 | 1.03 (−) |
2 | 1.89 (+) | 1.98 | 2.83 | 1.94 | 3.59 | 1.27 (−) |
3 | 2.64 (+) | 4.57 | 3.35 | 6.95 | 2.55 | 2.94 (+) |
4 | 1.54 (+) | 1.54 | 0.90 | 0.97 | 0.95 | 0.97 (−) |
5 | 2.90 (+) | 4.28 | ND | 1.33 | 1.27 | 1.09 (−) |
6 | 2.29 (+) | 1.21 | 1.25 | 1.18 | 1.12 | 0.84 (−) |
7 | 2.16 (+) | 1.92 | 1.87 | 1.80 | 1.73 | 1.73 (+) |
8 | 2.23 (+) | 1.89 | 1.73 | 1.76 | 1.82 | 0.88 (−) |
9 | 1.34 (+) | 1.30 | 1.36 | 1.37 | 0.97 | ND |
10 | 1.38 (+) | 1.41 | ND | 0.99 | ND | 0.90 (−) |
11 | 1.35 (+) | 1.39 | ND | 0.98 | ND | ND |
12 | 2.43 (+) | 2.04 | 1.01 | 0.71 | ND | ND |
13 | 1.37 (+) | 1.12 | ND | 0.95 | ND | ND |
14 | 1.70 (+) | 0.96 | 0.86 | ND | ND | 0.98 (−) |
15 | 1.97 (+) | 1.75 | ND | ND | 0.90 | 0.84 (−) |
16 | 1.35 (+) | 1.26 | ND | ND | 1.11 | 0.94 (−) |
17 | 1.51 (+) | ND | ND | 1.09 | 0.99 | 0.94 (−) |
18 | 1.63 (+) | 1.13 | 0.98 | 0.95 | ND | ND |
Eighteen positive women were followed up for 5 months after diagnosis and anti-trichomonas therapy administration; sera were harvested monthly and tested in ELISA to detect anti-Trichomonas vaginalis IgG class antibodies. Results are shown as an OD ratio of samples (mean values of duplicates) and controls (mean value of 20 children sera). >1.28 OD: positive (in bold), <1.28 and >1.186 borderline and <1.186 negative. (+), PCR positive; (−), PCR negative; ND, not detected.